SCHEMBL17848460

SCHEMBL17848460

O=C(CBr)Nc1ccccc1C(F)(F)F

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.65
GAA P10253 4/20 0.63
L3MBTL1 Q9Y468 1/20 0.59
KMT2A Q03164 2/20 0.58
MEN1 O00255 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.56
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 2/20 0.56
HTT P42858 1/20 0.55
LMNA P02545 1/20 0.54
MAPK1 P28482 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
HPGD P15428 1/20 0.54
CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19962677 0.88 GAA (0.70) POLBGAAL3MBTL1KMT2AMEN1
SCHEMBL5142574 0.87 POLB (0.76) POLBGAAL3MBTL1KMT2AMEN1
SCHEMBL13904851 0.85 POLB (0.49) POLBGAAL3MBTL1KMT2AMEN1
SCHEMBL26627737 0.84 POLB (0.67) POLBGAAL3MBTL1KMT2AMEN1
SCHEMBL4228980 0.84 KMT2A (0.49) POLBGAAL3MBTL1KMT2AMEN1
SCHEMBL5805358 0.83 POLB (0.65) POLBGAAL3MBTL1KMT2AMEN1
SCHEMBL4778269 0.83 POLB (0.65) POLBGAAL3MBTL1KMT2AMEN1
SCHEMBL4006020 0.83 POLB (0.65) POLBGAAL3MBTL1KMT2AMEN1
SCHEMBL5805356 0.83 POLB (0.65) POLBGAAL3MBTL1KMT2AMEN1
SCHEMBL4210730 0.83 ALDH1A1 (0.52) POLBGAAL3MBTL1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233077-B1 DOPAMINE D2 RECEPTOR LIGANDS BROAD INST INC (US) 2026-05-06 EP disclosed
US-12428373-B2 Dopamine D2 receptor ligands THE BROAD INSTITUTE, INC. (US) 2025-09-30 US disclosed
US-20230337677-A1 ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2023-10-26 US disclosed
US-20230143552-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2023-05-11 US disclosed
US-20230143552-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2023-05-11 US disclosed
US-20230143552-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2023-05-11 US disclosed
US-11498896-B2 Dopamine D2 receptor ligands THE BROAD INSTITUTE, INC. (US) 2022-11-15 US disclosed
US-20210147355-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2021-05-20 US disclosed
US-20210147355-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2021-05-20 US disclosed
US-10633336-B2 Dopamine D2 receptor ligands THE BROAD INSTITUTE, INC. (US) 2020-04-28 US disclosed
US-10633336-B2 Dopamine D2 receptor ligands THE BROAD INSTITUTE, INC. (US) 2020-04-28 US disclosed
US-20180155283-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2018-06-07 US disclosed
US-20180155283-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2018-06-07 US disclosed
US-20180155283-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2018-06-07 US disclosed
EP-3233077-A1 DOPAMINE D2 RECEPTOR LIGANDS The Broad Institute Inc. (US) 2017-10-25 EP disclosed
WO-2016100940-A1 DOPAMINE D2 RECEPTOR LIGANDS THE BROAD INSTITUTE, INC. (US) 2016-06-23 WO disclosed
CN-102675212-B N-substituted phenyl-2-((1H-benzimidazole-2-group) sulfydryl) amides derivatives and usage thereof UNIV KUNMING SCIENCE & TECHNOLOGY 2014-11-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180155283-A1 DOPAMINE D2 RECEPTOR LIGANDS DRD2, DRD3, ARRB1 POLB 3465/4885GAA 2661/4885L3MBTL1 1874/4885
US-11498896-B2 Dopamine D2 receptor ligands DRD2, SLC6A3, NTSR2 POLB 4468/4885GAA 2628/4885L3MBTL1 1719/4885
US-10633336-B2 Dopamine D2 receptor ligands DRD2, ARRB1, DRD3 POLB 4248/4885GAA 3339/4885L3MBTL1 2124/4885
US-20230143552-A1 DOPAMINE D2 RECEPTOR LIGANDS DRD2, SLC6A3, NTSR2 POLB 4468/4885GAA 2628/4885L3MBTL1 1719/4885
US-20210147355-A1 DOPAMINE D2 RECEPTOR LIGANDS DRD2, SLC6A3, NTSR2 POLB 4468/4885GAA 2628/4885L3MBTL1 1719/4885
US-12428373-B2 Dopamine D2 receptor ligands DRD2, SLC6A3, NTSR2 POLB 4468/4885GAA 2628/4885L3MBTL1 1719/4885
US-20230337677-A1 ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF DDT, ACHE, AHR POLB 4131/4885GAA 4686/4885L3MBTL1 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.